Vergleich

CD227

ArtNr 20-783-310140
Hersteller GENWAY
Menge 0.025 mg
Kategorie
Typ Antibody
Applikationen FC
Clon C595 (NCRC48
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-EDCAFA
Similar products 20-783-310140
Lieferbar
Genway ID:
GWB-EDCAFA
Specificity:
CD227
Specificity:
CD227
Clone:
C595 (NCRC48)
Immunogen:
Urinary MUC-1 mucin
Fusion Partner:
Spleen cells from immunised Balb/c mice were fused with cells of a mouse myeloma cell line.
Preparation:
Purified IgG prepared by affinity chromatography on Protein G
Buffer Solution:
Phosphate buffered saline pH7. 4
Preservative Stabilisers:
0. 09%Sodium Azide1%Bovine Serum AlbuminSuggested
Flow Cytometry:
Use 10ul of the suggested working dilution to label 106 cells in 100ul. Suggested
Dilution:
Flow Cytometry - Neat - 1/10
Function:
The alpha subunit has cell adhesive properties. Can act both as an adhesion and an anti-adhesion protein. May provide a protective layer on epithelial cells against bacterial and enzyme attack.
Function:
The beta subunit contains a C-terminal domain which is involved in cell signaling through phosphorylations and protein-protein interactions. Modulates signaling in ERK Src and NF-kappaB pathways. In activated T-cells influences directly or indirectly the Ras/MAPK pathway. Promotes tumor progression. Regulates P53-mediated transcription and determines cell fate in the genotoxic stress response. Binds together with KLF4 the PE21 promoter element of P53 and represses P53 activity.
Subunit:
The alpha subunit forms a tight non-covalent heterodimeric complex with the proteolytically-released beta-subunit. Interaction via the tandem repeat region with domain 1 of ICAM1 is implicated in cell migration and metastases. Isoform 1 binds directly the SH2 domain of GRB2 and forms a MUC1/GRB2/SOS1 complex involved in RAS signaling. The cytoplasmic tail (MUC1CT) interacts with several proteins such as SRC CTNNB1 and ERBs. Interaction with the SH2 domain of CSK decreases interaction with GSK3B. Interacts with CTNNB1/beta-catenin and JUP/gamma-catenin and promotes cell adhesion. Interaction with JUP/gamma-catenin is induced by heregulin. Binds PRKCD ERBB2 ERBB3 and ERBB4. Heregulin (HRG) stimulates the interaction with ERBB2 and to a much lesser extent the interaction with ERBB3 and ERBB4. Interacts with P53 in response to DNA damage. Interacts with KLF4. Interacts with estrogen receptor alpha/ESR1 through its DNA-binding domain and stimulates its transcription activity. Binds ADAM17.
Subcellular Location:
Apical cell membrane; Single-pass type I membrane protein. Note=Exclusively located in the apical domain of the plasma membrane of highly polarized epithelial cells. After endocytosis internalized and recycled to the cell membrane. Located to microvilli and to the tips of long filopodial protusions.
Subcellular Location:
Isoform 5: Secreted.
Subcellular Location:
Isoform 7: Secreted.
Subcellular Location:
Isoform 9: Secreted.
Subcellular Location:
Mucin-1 subunit beta: Cell membrane. Cytoplasm. Nucleus. Note=On EGF and PDGFRB stimulation transported to the nucleus through interaction with CTNNB1 a process which is stimulated by phosphorylation. On HRG stimulation colocalizes with JUP/gamma-catenin at the nucleus.
Tissue Specificity:
Expressed on the apical surface of epithelial cells especially of airway passages breast and uterus. Also expressed in activated and unactivated T-cells. Overexpressed in epithelial tumors such as breast or ovarian cancer and also in non-epithelial tumor cells. Isoform 7 expressed in tumor cells only. Developmental Stage: During fetal development expressed at low levels in the colonic epithelium from 13 weeks of gestation.
Ptm:
Highly glycosylated (N- and O-linked carbohydrates and sialic acid). O-glycosylated to a varying degree on serine and threonine residues within each tandem repeat ranging from mono- to penta-glycosylation. The average density ranges from about 50% in human milk to over 90% in T47D breast cancer cells. Further sialylation occurs during recycling. Membrane-shed glycoproteins from kidney and breast cancer cells have preferentially sialyated core 1 structures while secreted forms from the same tissues display mainly core 2 structures. The O-glycosylated content is overlapping in both these tissues with terminal fucose and galactose 2- and 3-linked galactose 3- and 3 6-linked GalNAc-ol and 4-linked GlcNAc predominating. Differentially O-glycosylated in breast carcinomas with 3 4-linked GlcNAc. N-glycosylation consists of high-mannose acidic complex-type and hybrid glycans in the secreted form MUC1/SEC and neutral complex-type in the transmembrane form MUC1/TM.
Ptm:
Proteolytic cleavage in the SEA domain occurs in the endoplasmic reticulum by an autoproteolytic mechanism and requires the full-length SEA domain as well as requiring a Ser Thr or Cys residue at the P + 1 site. Cleavage at this site also occurs on isoform MUC1/X but not on isoform MUC1/Y. Ectodomain shedding is mediated by ADAM17.
Ptm:
Dual palmitoylation on cysteine residues in the CQC motif is required for recycling from endosomes back to the plasma membrane.
Ptm:
Phosphorylated on tyrosines and serine residues in the C-terminal. Phosphorylation on tyrosines in the C-terminal increases the nuclear location of MUC1 and beta-catenin. Phosphorylation by PKC delta induces binding of MUC1 to beta-catenin/CTNNB1 and thus decreases the formation of the beta-catenin/E-cadherin complex. Src-mediated phosphorylation inhibits interaction with GSK3B. Src- and EGFR-mediated phosphorylation on Tyr-1229 increases binding to beta-catenin/CTNNB1. GSK3beta-mediated phosphorylation on Ser-1227 decreases this interaction but restores the formation of the beta-cadherin/E-cadherin complex. On T-cell receptor activation phosphorylated by LCK. PDGFR-mediated phosphorylation increases nuclear colocalization of MUC1CT and CTNNB1.
Polymorphism:
The number of repeats is highly polymorphic. It varies from 21 to 125 in the northern European population. The most frequent alleles contains 41 and 85 repeats. The tandemly repeated icosapeptide underlies polymorphism at three positions: PAPGSTAP[PAQT]AHGVTSAP[DT/ES]R DT -& gt; ES and the single replacements P -& gt; A P -& gt; Q and P-& gt; T. The most frequent replacement DT & gt; ES occurs in up to 50% of the repeats.
Similarity:
Contains 1 SEA domain. 1. Price. M. R. et al. (1990) Immunological and structural features of the protein core of human polymorphic epithelial mucin. 2. Price. M. R. et al. (1990) C595 - a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas. 3. Price. M. R. et al. (1991) Purification of anti-epithelial mucin monoclonal antibodies by epitope affinity chromatography. 4. Denton. G. et al. (1995) Primary sequence determination and molecular modelling of the variable region of an anti MUC1 mucin monoclonal antibody. 5. Denton. G. et al. (1997) Production and characterization of a recombinant anti Muc 1 scFv reactive with human carcinomas.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 0.025 mg
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen